DPP4 and Portal vein thrombosis: However, Lu et al.,43using data from spontaneous reporting systems of drug adverse events, conducted disproportionality analyses and found no signal of an association between DPP-4 inhibitors and VTE risk, though there were moderate to strong signals for risks of portal vein thrombosis, splenic vein thrombosis, and mesenteric vein thrombosis.